Efficacy of Levofloxacin-based Triple Therapy as a Second-line Therapy for H. pylori Eradication After Triple Therapy Failure

被引:0
|
作者
Mahachai, Varocha [1 ]
Thongbai, Thirada [2 ]
Vilaichone, Ratha-korn [3 ]
机构
[1] Chulalongkorn Univ Hosp, Dept Med, Div Gastroenterol, Bangkok, Thailand
[2] Cent Hosp, Dept Med, Bangkok, Thailand
[3] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Pathum Thani, Thailand
来源
关键词
D O I
10.14309/00000434-201110002-00105
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
105
引用
收藏
页码:S43 / S43
页数:1
相关论文
共 50 条
  • [41] Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple "Sequential" or "Concomitant" Treatment to Eradicate H. pylori Infection
    Gisbert, Javier P.
    Molina-Infante, Javier
    Marin, Alicia C.
    Rodriguez, Gema Vinagre
    Barrio, Jesus
    McNicholl, Adrian G.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S334 - S334
  • [42] Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection
    Gisbert, Javier P.
    Molina-Infante, Javier
    Marin, Alicia C.
    Vinagre, Gemma
    Barrio, Jesus
    McNicholl, Adrian Gerald
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (06) : 652 - 656
  • [43] The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
    Tai, Wei-Chen
    Lee, Chen-Hsiang
    Chiou, Shue-Shian
    Kuo, Chung-Mou
    Kuo, Chung-Huang
    Liang, Chih-Ming
    Lu, Lung-Sheng
    Chiu, Chien-Hua
    Wu, Keng-Liang
    Chiu, Yi-Chun
    Hu, Tsung-Hui
    Chuah, Seng-Kee
    [J]. PLOS ONE, 2014, 9 (08):
  • [44] Levofloxacin-Based Sequential Therapy vs Clarithromycin-Based Sequential Therapy for Eradication of H. pylori Infection
    Romano, Marco
    Gravina, Antonietta G.
    Federico, Alessandro
    Miranda, Agnese
    Gerardo, Nardone
    Rocco, Alba
    Gaeta, Laura
    Salerno, Raffaele
    Tiso, Angelo
    Bianco, Maria Antonia
    Cuomo, Antonio
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S335 - S335
  • [45] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [46] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez Bermejo, M.
    Molina Infante, J.
    Perez Gallardo, B.
    Prieto Bermejo, A.
    Mateos Rodriguez, J.
    Robledo Andres, P.
    Gonzalez Garcia, G.
    [J]. HELICOBACTER, 2007, 12 (04) : 432 - 432
  • [47] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez-Bermejo, M.
    Molina-Infante, J.
    Perez-Gallardo, B.
    Prieto-Bermejo, A.-B.
    Mateos-Rodriguez, J.-M.
    Robledo-Andres, P.
    Gonzalez-Garcia, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 495 - 500
  • [48] Impact of efficacies of dual therapy and triple therapy using rabeprazole for the second-line eradication therapy of Helicobacter pylori in Japan
    Kawai, T
    Kawakami, K
    Takei, K
    Kataoka, M
    Itoi, T
    Moriyasu, F
    Takagi, Y
    Aoki, T
    Rinbara, E
    Noguchi, N
    Sasatsu, M
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A428 - A428
  • [49] Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy:: A multicentre study
    Zullo, A.
    De Francesco, V.
    Scaccianoce, G.
    Manes, G.
    Efrati, C.
    Hassan, C.
    Maconi, G.
    Pighonica, D.
    Cannaviello, C.
    Panella, C.
    Morini, S.
    Lerardi, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (09) : 806 - 810
  • [50] Helicobacter pylori eradication rate of levofloxacin-based therapy
    Koo, Jiyeon
    Lee, Sihyung
    Kang, Minkyu
    Kim, Mincheol
    Park, Byungsam
    Jang, Byungik
    Kim, Taenyun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 354 - 354